drugset / Trial / NCT02653742

Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children

NCT02653742

Phase 4 Unknown 150 enrolled Anica Crnkovic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of ketorolac sublingual with fentanyl intranasal used in our hospital for pain control in children undergoing bilateral myringotomy with placement of pressure equalization tubes (BMTs).

Timeline

Start
2015-05
Primary completion
2022-12
Completion
2022-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 2 mg/kg Intranasal
Subject Ketorolac Other / unclassified 1 mg/kg Other